University of Michigan: Liver Diseases trials

The registry lists 11 Liver Diseases studies with University of Michigan as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 4No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The University of Michigan Wellness for Liver Health StudyCompletedNCT05010070Phase 1/2Results posted
• The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.CompletedNCT04675775Not applicableResults posted
• Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment TrialCompletedNCT04473482Not applicableResults posted
• Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT03839082Not applicableResults posted
• Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsCompletedNCT01975935Phase 2Results posted
• Amlexanox for Type 2 Diabetes and ObesityTerminatedNCT01842282Phase 2Results posted
• Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With LipodystrophyCompletedNCT01679197Phase 2Results posted
• Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD TrialCompletedNCT03493204Not applicable
• Is Eovist Suitable for Arterial-Phase MR Imaging of LiverCompletedNCT02684526Not applicable
• 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic ShuntsCompletedNCT02046473Not applicable
• Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery CandidatesCompletedNCT00887393Not applicable